Policy & regulation

The US Food and Drug Administration (FDA) has approved a second therapy for geographic atrophy (GA), with IZERVAY (avacincaptad pegol...

Greater scrutiny of sexual misconduct in the healthcare system has led to sustained jump in reports to authorities as well...

The global health sector will continue to lose out unless measures are taken to accelerate towards equal representation of women...

To help practitioners, including optometrists, better understand and meet their health record management obligations, seven of Ahpra’s national boards have...

In his second Federal Budget since coming into power, Health Minister Mr Mark Butler has made Medicare reform his number...

“If you want to ruin a doctor’s life, all you have to do is make a complaint against them and...

An independent review into Medicare compliance has found no evidence of the $8 billion fraud quoted in media reports last...

Optometry services have been subsidised by the Australian Government since Medicare (then Medibank) was first introduced in 1975. This has...

Optometry Australia (OA) is urging caution over potential changes to the way Ahpra uses its register, with the regulator considering...

Practitioners, stakeholders and the community have until 14 February 2023 to provide feedback on an Ahpra review of healthcare professional’s...